R. Cicuéndez

Low anti‐SARS‐CoV‐2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID‐19 patients

P. Enríquez, F. Barbé, D. Kelvin, 2021, Journal of internal medicine.

Sustained value of proadrenomedullin as mortality predictor in severe sepsis.

J. Bermejo‐Martin, D. Andaluz-Ojeda, L. Nogales, 2015, The Journal of infection.

In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

A. Nini, L. Fuchs, J. Maessen, 2022, The Lancet Respiratory Medicine.

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

P. Enríquez, F. Barbé, D. Kelvin, 2020, Critical Care.

MR‐ proADM to detect specific types of organ failure in infection

C. Aldecoa, M. Martín-Fernández, R. Almansa, 2020, European journal of clinical investigation.

Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity

J. Quenot, P. Charles, J. Eiros, 2017, Annals of Intensive Care.

Absent or insufficient anti-SARS-CoV-2 S antibodies at ICU admission are associated to higher viral loads in plasma, antigenemia and mortality in COVID-19 patients

P. Enríquez, F. Barbé, D. Kelvin, 2021, medRxiv.

SARS-CoV-2-RNA viremia is associated to hypercytokinemia and critical illness in COVID-19

P. Enríquez, F. del Campo, C. Aldecoa, 2020, medRxiv.